Less logistically demanding tools for quantifying exchanges across streambeds have been developed and include drive-point mini-piezometers, seepage meters, and temperature profiling tools.
As a consequence donor care bundle pathways have been developed and include targets for mean arterial pressures and cardiac output amongst other physiological parameters [ 1].
Furthermore, noninvasive techniques for the evaluation of ICP have been developed and include computed tomography (CT) scan of the head, ophthalmoscopy and transcranial Doppler sonography (TCD).
Nevertheless, therapeutic approaches for enhancing incretin action have been developed and include degradation-resistant GLP-1 receptor agonists, and increasing levels of GLP-1 indirectly by inhibition of DPP-4 [ 10].
Antibodies recognizing different type II collagen fragments have been developed and include those directed against the neo-epitopes generated by the collagenases, and against C-telopeptide breakdown fragments (CTX-II).
A number of engineering strategies to improve NADPH provision in C. glutamicum have been developed and include, e.g., transmembrane transhydrogenase PntAB [ 65], phosphoglucose isomerase mutants [ 66], NADPH-dependent glyceraldehyde-3-phosphate dehydrogenase [ 67], or NAD kinase [ 68].
